1 study found for:    23569308 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Docetaxel;   Drug: ZD4054;   Drug: Placebo

Indicates status has not been verified in more than two years